3 active not recruiting, 3 recruiting, 2 completed, 1 not yet recruiting. 3 Not applicable, 3 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 2, Unknown 1 |
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow (18F)fluoroethyltyrosine: new trials by email Literature Review of (18F)fluoroethyltyrosine trials Research Report on (18F)fluoroethyltyrosine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings fluoroethyl-L tyrosine (18F) - Functional Pituitary Adenomas | Phase 2 | Not yet recruiting | University Hospital, Lille | 30 | 2026-09-01 | 2026-05-06 |
| 99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging 99mTc-1-thio-D-glucose, 18F-FET - Glioma (Any Grade) in the Brain | Not applicable | Active not recruiting | Tomsk National Research Medical Center of the Russian Academy of Sciences | 40 | 2026-02-15 | 2026-06-24 |
| Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET 18F-FDG (oral), 18F-FDG (intravenous), 18F-FET (oral) - Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease) | Not applicable | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 36 | 2024-11-05 | 2026-02-02 |
| Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm Fluorethyltyrosine (18-F), Positron Emission Tomography (PET) - Intracranial Neoplasm | Recruiting | Thomas Hope | 199 | 2024-06-21 | 2026-08-27 | |
| Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI - High Grade Glioma | Early Phase 1 | Recruiting | University of Alabama at Birmingham | 20 | 2024-03-07 | 2026-08-20 |
| Registering Genomics and Imaging of Tumors (ReGIT) FET F-18, O-15 Radioisotope, CT scan - Glioma | Recruiting | Indiana University | 20 | 2023-07-18 | 2025-09-15 | |
| 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) 131I-IPA - Neoplastic Disease, Glioblastoma | Phase 1 | Active not recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 12 | 2023-04-01 | 2026-08-13 |
| Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma [18F]FET - Patients With Suspected or Diagnosed Central Nervous System Lymphoma | Not applicable | Unknown | Asan Medical Center | 30 | 2021-08-27 | 2021-10-19 |
| Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms F-18 Fluoroethyltyrosine (FET), Positron Emission Tomography (PET) - Intracranial Neoplasm, Low Grade Glioma | Phase 2 | Completed | Thomas Hope | 143 | 2018-10-29 | 2026-03-11 |
| FET-PET for Evaluation of Response of Recurrent GBM to Avastin 18F-FET - Glioblastoma Multiforme, GBM | Phase 2 | Completed | Marcelo F. Di Carli, MD, FACC | 13 | 2013-02-01 | 2019-10-30 |
Glioblastoma (4) · Brain Neoplasms (3) · Glioma (3) · Neoplasms (1) · Non-alcoholic Fatty Liver Disease (1)
Thomas Hope (2) · Asan Medical Center (1) · Copenhagen University Hospital, Rigshospitalet (1) · Indiana University (1) · Marcelo F. Di Carli, MD, FACC (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1) · Tomsk National Research Medical Center of the Russian Academy of Sciences (1) · University Hospital, Lille (1) · University of Alabama at Birmingham (1)
United States (5) · Australia (1) · Austria (1) · Denmark (1) · France (1) · Netherlands (1) · Russia (1) · South Korea (1)
Jason Parker, PhD (1) · Jonathan McConathy, MD (1) · Michael Thomas, MD (1) · Raymond L Huang, MD (1) · Thomas A Hope, MD (1) · Vladimir I Chernov, MD, Prof. (1)